Home
Conditions
Carcinoma

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,805 public trials 2,094 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma trial results

Recruiting

Tislelizumab or Tislelizumab Combined With Lenvatinib Neo-adjuvant Treatment for Resectable RHCC

NCT04615143

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Comparison of Multi-omics Models for Early Nasopharyngeal Carcinoma Screening: CfDNA Methylation, EBV DNA, and Serological Double-antibodies Detection

NCT06763289

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +12 more
Locations: The First Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery

NCT06762782

Conditions: Adenocarcinoma, Adjuvant Therapy in Patients With Hepatocellular Carcinoma (HCC) at High Risk of Recurrence After Curative Resection or Ablation, Carcinoma, +10 more
Locations: The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Recruiting

The ABC-HCC Trial: Atezolizumab Plus Bevacizumab vs. Transarterial Chemoembolization (TACE) in Intermediate-stage HepatoCellular Carcinoma

NCT04803994

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: LKH - Univ. Klinikum Graz Graz, Austria

Medzinische Universität Innsbruck Innsbruck, Austria

Klinikum Klagenfurt am Wörthersee Klagenfurt, Austria

Ordensklinikum Linz Linz, Austria

View all 72 locations

View Trial Details

Recruiting

TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients with Hepatocellular Carcinoma

NCT06114082

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Recruiting

Radiation Major Hepatectomy to Selectively Treat Large Unifocal Hepatocellular Carcinoma

NCT06178198

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Recruiting

Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney (COMPAR-K)

NCT06290427

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations: Urology Unit, AOUI Verona Verona, VR, Italy

View Trial Details

Recruiting

Using a 3D Culture Model for Circulating Tumor Cells Combined With Molecular Bioassays in Patients With HNSCC Cancer

NCT06755762

Conditions: Carcinoma, Carcinoma, Squamous Cell, Circulating Tumor Cell, +12 more
Locations: Chang Gung Memorial Hospital Taoyuan, Taiwan

View Trial Details

Recruiting

Ultrasound-Guided Microwave Ablation Vs. Surgery for Low-Risk PapilaryThyroid Carcinoma

NCT06725576

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Carcinoma, +10 more
Locations: Sun Yat-sen Memorial Hospital, Sun Yat-sen University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Fruquintinib After ICIs Treatment in Unresectable Hepatocellular Carcinoma

NCT06446154

Conditions: Adenocarcinoma, Anti-angiogenic Therapy, Carcinoma, +12 more
Locations: Sun Yat-sen university cancer center Guangzhou, Guangdong, China

View Trial Details

Carcinoma

Carcinoma trial results

Related conditions